
Sema GLP-1
Semaglutide is a GLP-1 receptor agonist that mimics the effects of glucagon-like peptide-1, helping regulate blood sugar and suppress appetite.
Half-life
About 7 days
Delivery
Subcutaneous injection
Suggested dosage
Not specified
Usage
Mechanism of action
Benefits (4)
- Appetite suppression
- Weight loss
- Improved blood sugar control
- Reduced risk of cardiovascular events
Side effects (4)
- Nausea
- Constipation
- Headache
- Loss of appetite

